Our core data analytics technology has been developed and refined by our founders since 2008. This technology has been used in eight clinical studies and has been the core tool to perform medical research described in more than 20 peer-reviewed scientific publications.
Integrated genomic and epigenomic analysis of breast cancer brain metastasis.
Long insert whole genome sequencing for copy number variant and translocation detection.
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing.
Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.